Detroit’s top three carmakers are calling for increased efforts to break down market barriers with South Korea, claiming the current Korea Free Trade agreement has been insufficient in exporting products to the nation.
Ford Motor Co. recently spoke out against the Canada-South Korea free trade agreement as yet another failure of efforts to boost exports.
Ford also slammed similar agreements with the US and EU, arguing that “over the last two years, both the United States and European Union free trade agreements with South Korea have failed to reverse this one-sided automotive trade flow because the South Korean government continues its long history of maintaining a closed market through non-tariff trade barriers and actively intervening in its currency to unfairly subsidize its exports and protect its home market.”
The US trade agreement with South Korea is now two years old. Ford said in a statement that since the agreement was made, the “US trade deficit has worsened by more than 50 percent and the volume of US goods exported to South Korea – not just autos but all exports – has dropped nearly $2 billion.”
The claims were backed by the American Automotive Policy Council, reports say, that agreed South Korea has not opened its market enough to foreign imports. Reports say the groups also claim that “competition policy issues are creating a very difficult business environment for foreign companies operating in Korea.”
Full Content: Detroit News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas